IN RE: COPAXONE ANTITRUST LITIGATION
Case Number:
2:22-cv-01232
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
- Albertsons Cos. Inc.
- Cardinal Health Inc.
- Cencora Inc.
- H.D. Smith LLC
- McKesson Corp.
- Morris & Dickson Co. LLC
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
Sectors & Industries:
-
April 13, 2026
Mylan Can't Revive Copaxone Antitrust Claims Against Teva
A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment.
-
March 03, 2025
Teva Should Face Key Copaxone Antitrust Claims, Court Told
Mylan and pharmaceutical wholesalers should be allowed to proceed with some, but not all, parallel claims accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment, a special master has recommended in New Jersey federal court.
-
March 07, 2022
Teva Stalled Generics For Blockbuster MS Drug, Buyers Say
Teva Pharmaceuticals was hit with a proposed class action Monday, with pharmacies and other purchasers accusing the drugmaker of unlawfully suppressing generic competition for its $3 billion-a-year multiple sclerosis treatment Copaxone by entering into exclusionary contracts and spreading misinformation about the generics.